Disease: Lipodystrophy- familial partial- type 2
- A cohort analysis of familial partial lipodystrophy from two Mediterranean countries
- A Comprehensive Update on the Chylomicronemia Syndrome
- A promising treatment for spontaneous ovarian hyperstimulation syndrome due to familial partial lipodystrophy: GnRH analogs combined with cyst aspiration
- A recurrent familial partial lipodystrophy due to a monoallelic or biallelic LMNA founder variant highlights the multifaceted cardiac manifestations of metabolic laminopathies
- A recurrent homozygous LMNA missense variant p.Thr528Met causes atypical progeroid syndrome characterized by mandibuloacral dysostosis, severe muscular dystrophy, and skeletal deformities
- A Very-Low Calorie Diet Can Cause Remission of Diabetes Mellitus and Hypertriglyceridemia in Familial Partial Lipodystrophy
- A Very-Low-Calorie Diet Can Cause Remission of Diabetes Mellitus and Hypertriglyceridemia in Familial Partial Lipodystrophy
- Adenine base editing to treat progeria syndrome and extend the lifespan
- Adipocyte-Specific Deletion of Lamin A/C Largely Models Human Familial Partial Lipodystrophy Type 2
- Advances in the care of lipodystrophies
- APOC3 inhibition with volanesorsen reduces hepatic steatosis in patients with severe hypertriglyceridemia
- Assessment of efficacy and safety of volanesorsen for treatment of metabolic complications in patients with familial partial lipodystrophy: Results of the BROADEN study: Volanesorsen in FPLD; The BROADEN Study
- Cardiac phenotype in familial partial lipodystrophy
- Case Report: A New Peroxisome Proliferator-Activated Receptor Gamma Mutation Causes Familial Partial Lipodystrophy Type 3 in a Chinese Patient
- Case Report: An Atypical Form of Familial Partial Lipodystrophy Type 2 Due to Mutation in the Rod Domain of Lamin A/C
- Case Report: Metreleptin Treatment in a Patient With a Novel Mutation for Familial Partial Lipodystrophy Type 3, Presenting With Uncontrolled Diabetes and Insulin Resistance
- Case report: two novel PPARG pathogenic variants associated with type 3 familial partial lipodystrophy in Brazil
- Cellular Metabolism and Bioenergetic Function in Human Fibroblasts and Preadipocytes of Type 2 Familial Partial Lipodystrophy
- Circulating exosomal circRNA-miRNA-mRNA network in a familial partial lipodystrophy type 3 family with a novel PPARG frameshift mutation c.418dup
- Clinical and imaging features of women with polygenic partial lipodystrophy: a case series
- Clinical characteristics and efficacy of pioglitazone in a Japanese patient with familial partial lipodystrophy due to peroxisome proliferator-activated receptor gamma gene mutation
- Clinical characteristics and efficacy of pioglitazone in a Japanese patient with familial partial lipodystrophy due to peroxisome proliferator-activated receptor γ gene mutation
- Clinical Spectrum of <em>LMNA</em>-Associated Type 2 Familial Partial Lipodystrophy: A Systematic Review
- Clinical Spectrum of LMNA-Associated Type 2 Familial Partial Lipodystrophy: A Systematic Review
- Comprehensive analysis of morbidity and mortality patterns in familial partial lipodystrophy patients: insights from a population study
- Describing the natural history of clinical, biochemical and radiological outcomes of children with familial partial lipodystrophy type 2 (FPLD2) from the United Kingdom: A retrospective case series
- Development and Clinical Applications of Antisense Oligonucleotide Gapmers
- Development of Antisense Oligonucleotide Gapmers for the Treatment of Dyslipidemia and Lipodystrophy
- Diagnostic and referral pathways in patients with rare lipodystrophy and insulin-resistance syndromes: key milestones assessed from a national reference center
- Drosophila Models Reveal Properties of Mutant Lamins That Give Rise to Distinct Diseases
- Dunnigan lipodystrophy syndrome: French National Diagnosis and Care Protocol (PNDS; Protocole National de Diagnostic et de Soins)
- Early Atherosclerosis and Conduction Defect in a Rare Case of Dunnigan Type Familial Partial Lipodystrophy
- Echocardiographic Alterations of Cardiac Geometry and Function in Patients with Familial Partial Lipodystrophy
- Effect of β-Estradiol on Adipogenesis in a 3T3-L1 Cell Model of Prelamin A Accumulation
- Efficacy and Safety of Glucagon-Like Peptide 1 Agonists in a Retrospective Study of Patients With Familial Partial Lipodystrophy
- Familial partial lipodystrophy syndromes
- Familial partial lipodystrophy type 2 and obesity, two adipose tissue pathologies with different inflammatory profiles
- Familial Partial Lipodystrophy-Literature Review and Report of a Novel Variant in <em>PPARG</em> Expanding the Spectrum of Disease-Causing Alterations in FPLD3
- Familial Partial Lipodystrophy-Literature Review and Report of a Novel Variant in PPARG Expanding the Spectrum of Disease-Causing Alterations in FPLD3
- Familial Partial Lipodystrophy: Clinical Features, Genetics and Treatment in a Greek Referral Center
- Familial Screening for the Prevention of Rare Diseases: A Focus on Lipodystrophy in Southern Saudi Arabia
- Genomic loci mispositioning in Tmem120a knockout mice yields latent lipodystrophy
- Genotype - phenotype correlation in an adolescent girl with pathogenic PPARy genetic variation that caused severe hypertriglyceridemia and early onset type 2 diabetes
- Gestational and neonatal outcomes of women with partial Dunnigan lipodystrophy
- High-throughput Second-generation Sequencing Technology Assisted Diagnosis of Familial Partial Lipodystrophy (Type 2 Kobberling-Dunnigan Syndrome): A Case Report
- Hypertriglyceridemia
- Hypertriglyceridemia Results From an Impaired Catabolism of Triglyceride-Rich Lipoproteins in PLIN1-Related Lipodystrophy
- Impact of Combined Baricitinib and FTI Treatment on Adipogenesis in Hutchinson-Gilford Progeria Syndrome and Other Lipodystrophic Laminopathies
- Impaired Muscle Mitochondrial Function in Familial Partial Lipodystrophy
- Increased musculature: A warning sign of familial partial lipodystrophy
- Inguinal Fat Compensates Whole Body Metabolic Functionality in Partially Lipodystrophic Mice with Reduced PPARγ Expression
- Isolated Congenital Lower Limb Lipoatrophy: A Case Report and Literature Review
- Labia Majora Hypertrophy in a Patient Affected by Familial Partial Lipodystrophy Type 5: A Case Report on Diagnosis, Presentation, and Surgical Correction
- Lipoatrophic diabetes in familial partial lipodystrophy type 2: From insulin resistance to diabetes
- Lipodystrophies
- Lipodystrophies
- Lipodystrophy for the Diabetologist-What to Look For
- Lipomatoses
- LMNA Mutations G232E and R482L Cause Dysregulation of Skeletal Muscle Differentiation, Bioenergetics, and Metabolic Gene Expression Profile
- Loss of Mature Lamin A/C Triggers a Shift in Intracellular Metabolic Homeostasis via AMPKα Activation
- Metreleptin (Myalepta): CADTH Reimbursement Recommendation: Indication: As an adjunct to diet as a replacement therapy to treat the complications of leptin deficiency in lipodystrophy (LD) patients: with confirmed congenital generalised LD (Berardinelli-S
- Mineralocorticoid Receptor Antagonism Prevents Type 2 Familial Partial Lipodystrophy Brown Adipocyte Dysfunction
- Molecular and Mechanobiological Pathways Related to the Physiopathology of FPLD2
- Navigating Lipodystrophy: Insights from Laminopathies and Beyond
- Nephrotic range proteinuria associated with focal segmental glomerulosclerosis reversed with pioglitazone therapy in a patient with Dunnigan type lipodystrophy
- Novel clinical features and pleiotropic effect in three unrelated patients with LMNA variant
- Nuclear lamins: Structure and function in mechanobiology
- Observation of p.R4810K, a Polymorphism of the Mysterin Gene, the Susceptibility Gene for Moyamoya Disease, in Two Female Japanese Diabetic Patients with Familial Partial Lipodystrophy 1
- Partial Lipodystrophy and LMNA p.R545H Variant
- Partial lipodystrophy: Clinical presentation and treatment
- Patients' perspective on the medical pathway from first symptoms to diagnosis in genetic lipodystrophy
- Pelvis Magnetic Resonance Imaging to Diagnose Familial Partial Lipodystrophy
- Perilipin 1: a systematic review on its functions on lipid metabolism and atherosclerosis in mice and humans
- Phenotypic Differences Among Familial Partial Lipodystrophy Due to <em>LMNA</em> or <em>PPARG</em> Variants
- Phenotypic Differences Among Familial Partial Lipodystrophy Due to LMNA or PPARG Variants
- Podocytopathies associated with familial partial lipodystrophy due to LMNA variants: report of two cases
- Prevalence of severe hypertriglyceridemia and pancreatitis in familial partial lipodystrophy type 2
- Primary disease of adipose tissue: When to think about and how to evaluate it in clinical practice?
- Rapid response to leptin therapy in a FPLD patient with a novel PPARG missense variant
- Rare Diagnosis of Familial Partial Lipodystrophy in a Patient With Life-Threatening Pancreatitis due to Hypertriglyceridemia
- Rare monogenic causes of steatotic liver disease masquerading as MASLD
- Recognize rare diseases by the adipose tissue : Lipodystrophy-actually simple but nevertheless often overlooked
- Refining Evaluation of Bone Mass and Adipose Distribution in Dunnigan Syndrome
- Relationship of fat mass ratio - a biomarker for lipodystrophy - with cardiometabolic traits
- Relationship of Fat Mass Ratio, a Biomarker for Lipodystrophy, With Cardiometabolic Traits
- RIPK3 dampens mitochondrial bioenergetics and lipid droplet dynamics in metabolic liver disease
- Selective targeting of angiopoietin-like 3 (ANGPTL3) with vupanorsen for the treatment of patients with familial partial lipodystrophy (FPLD): results of a proof-of-concept study
- Serum levels of adiponectin differentiate generalized lipodystrophies from anorexia nervosa
- SEVERE HYPERTRIGLYCERIDEMIA ASSOCIATED WITH EVEROLIMUS TREATMENT AFTER HEART TRANSPLANTATION
- Severe loss of adipose tissue in a Vietnamese lipodystrophy patient caused by <em>LMNA</em> p.G465D mutation: a first clinical characterization and two-year follow-up
- Severe loss of adipose tissue in a Vietnamese lipodystrophy patient caused by LMNA p.G465D mutation: a first clinical characterization and two-year follow-up
- The Efficacy and Safety of Glucagon-Like Peptide-1 Agonists in a Retrospective Study of Patients With Familial Partial Lipodystrophy
- The Influence of a Conjugated Pneumococcal Vaccination on Plasma Antibody Levels against Oxidized Low-Density Lipoprotein in Metabolic Disease Patients: A Single-Arm Pilot Clinical Trial
- The Metabolic Equivalent BMI in Patients with Familial Partial Lipodystrophy (FPLD) Compared with Those with Severe Obesity
- Understanding Cardiac Alterations in Familial Partial Lipodystrophy: Insights from Echocardiography
- Variable Expressivity and Allelic Heterogeneity in Type 2 Familial Partial Lipodystrophy: The p.(Thr528Met) LMNA Variant
- Variable Expressivity in Type 2 Familial Partial Lipodystrophy Related to R482 and N466 Variants in the LMNA Gene
- Visualisation pattern of fat distribution of a rare disorder: familial partial lipodystrophy (FPLD)
- Volanesorsen in the Treatment of Familial Chylomicronemia Syndrome or Hypertriglyceridaemia: Design, Development and Place in Therapy
- Waist circumference is independently associated with liver steatosis and fibrosis in LMNA-related and unrelated Familial Partial Lipodystrophy women